What to watch with Omega-3 Index and menopause?

The Omega-3 Index (percentage of EPA+DHA in red blood cell membranes) is a validated biomarker for cardiovascular risk. During menopause, declining estrogen increases risks for heart disease, inflammation, and mood disturbances. A low index (<4 %) is associated with higher triglycerides, more severe hot flashes, and depressive symptoms. A target range of 8–12 % is often suggested, but specific menopause intervention trials with hard endpoints are lacking. Evidence is mainly observational or extrapolated from cardiovascular studies. Caution: omega-3 supplements can increase bleeding risk when combined with anticoagulants or aspirin. Individual needs vary based on genetics (e.g., FADS1/2 variants) and inflammatory status. The test alone does not replace clinical evaluation of menopausal symptoms. Its predictive value is limited without concurrent assessment of oxidative stress or lipid profile. Overall: a useful guide, not a magic bullet.